CSL Behring and the GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) have successfully concluded negotiations on the reimbursement price of HEMGENIX®. This agreement marks ...
The interplay between aging and cellular senescence reveals insights into chronic inflammation and potential strategies for enhancing healthspan and longevity.
IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to 15 kb.
In this interview, Technology Networks talked to Dr. Stacy Lindborg, president, chief executive officer and board member at IMUNON, Inc., who shares how its PlaCCine® platform could reshape vaccine ...
Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...
With a grant award from the American Mosquito Control Association Research Fund, Utah State University ecologist Norah ...
On March 23, direct-to-consumer genetic testing company 23andMe announced it had filed for bankruptcy. The move came after ...
Epicrispr Biotechnologies to Begin Clinical Trials for its Lead Epigenetic Therapy for FSHD Patients
The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.
Chennai’s high pollution, fast-paced life, and disease risks make health insurance essential to cover medical expenses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback